TASURGRATINIB

UNII:	TN7CUD1NGA
Formula:	C₃₂H₃₇N₅O₆
Preferred Substance Name:	TASURGRATINIB
InChIKey:	IBHOLSBDZMIPPT-UHFFFAOYSA-N

1622204-21-0
1-(2-HYDROXYETHYL)-7-(2-METHOXYETHOXY)-N-METHYL-3- OXO-7H-6-OXA-4-AZA-7(5)-INDOLA-5(2,4)-PYRIDINA-1(4)-PIPERIDINA-2(1,4)-BENZENAHEPTAPHANE-7-CARBOXAMIDE
1H-INDOLE-1-CARBOXAMIDE, 5-((2-((4-(1-(2-HYDROXYETHYL)-4-PIPERIDINYL)BENZOYL)AMINO)-4-PYRIDINYL)OXY)-6-(2-METHOXYETHOXY)-N-METHYL-
5-((2-(((4-(1-(2-HYDROXYETHYL)PIPERIDIN-4-YL)PHENYL)CARBONYL)AMINO)PYRIDIN-4-YL)OXY)-6-(2-METHOXYETHOXY)-N-METHYL-1H-INDOLE-1-CARBOXAMIDE
E7090
E-7090
FGF/FGFR PATHWAY INHIBITOR E7090
TASURGRATINIB [INN]
TASURGRATINIB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TASURGRATINIB

Synonyms and Mappings

Resources